June 29, 2020 / 11:58 AM / 9 days ago

BRIEF-Akebia Therapeutics Reports Approval Of Vadadustat In Japan

June 29 (Reuters) - Akebia Therapeutics Inc:

* AKEBIA THERAPEUTICS ANNOUNCES APPROVAL OF VADADUSTAT IN JAPAN FOR THE TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE IN DIALYSIS-DEPENDENT AND NON-DIALYSIS DEPENDENT ADULT PATIENTS

* AKEBIA THERAPEUTICS INC - VADADUSTAT WILL BE MARKETED BY MTPC IN JAPAN UNDER TRADE NAME VAFSEO Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below